Novartis enlists Dren Bio to co-develop bispecific antibodies for $3 billion
Eager to tap into a high-growth market, Novartis has sealed a pact worth up to $3 billion with Dren Bio to co-develop antibody treatments for cancer.
Archives for July 30, 2024
BeiGene new flagship biologics manufacturing facility opens after $800M investment
BeiGene, a global oncology company, has announced the opening of its flagship US facility, which will expand the company’s biologics manufacturing capabilities and clinical research and development activities.
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
A committee from the European Medicines Agency (EMA) has voted against granting Leqembi (lecanemab) a marketing authorization due to the risk of serious side effects associated with the treatment.
Women in Science - Tehmina Masud - the importance of growing outside your comfort zone
A book, a computer and some sage words from her physicist father set Tehmina on her path to a successful career in science.
Explore how Lonza's experts tackle parenteral drug and bioconjugate development challenges
In the rapidly evolving field of pharmaceuticals, the development of parenteral drugs and bioconjugates presents unique challenges and opportunities.